Which has stronger earnings & valuation, FEIM or ALMR?

Frequency Electronics has higher earnings, but lower revenue than Alamar Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Frequency Electronics $69.81M 9.72 $23.69M $0.75 91.96 Alamar Biosciences $87.16M 18.24 N/A N/A N/A

Frequency Electronics (FEIM) Competitors

$68.97 -0.76 (-1.09%)

As of 06/23/2026 04:00 PM Eastern

Compare

FEIM vs. ALNT, ALMR, EYPT, TRNS, and CTKB

Should you buy Frequency Electronics stock or one of its competitors? MarketBeat compares Frequency Electronics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Frequency Electronics include Allient (ALNT), Alamar Biosciences (ALMR), Eyepoint Pharmaceuticals (EYPT), Transcat (TRNS), and Cytek Biosciences (CTKB). These companies are all part of the "measuring and control equipment" industry.

How does Frequency Electronics compare to Allient?

Allient (NASDAQ:ALNT) and Frequency Electronics (NASDAQ:FEIM) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

61.6% of Allient shares are held by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are held by institutional investors. 15.0% of Allient shares are held by insiders. Comparatively, 28.0% of Frequency Electronics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Allient presently has a consensus price target of $77.33, suggesting a potential downside of 19.47%. Frequency Electronics has a consensus price target of $43.67, suggesting a potential downside of 36.69%. Given Allient's higher probable upside, equities research analysts clearly believe Allient is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Allient	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

Allient has a beta of 1.63, meaning that its stock price is 63% more volatile than the broader market. Comparatively, Frequency Electronics has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market.

In the previous week, Allient had 2 more articles in the media than Frequency Electronics. MarketBeat recorded 2 mentions for Allient and 0 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 1.00 beat Allient's score of 0.09 indicating that Frequency Electronics is being referred to more favorably in the news media.

Company	Overall Sentiment
Allient	Neutral
Frequency Electronics	Positive

Frequency Electronics has lower revenue, but higher earnings than Allient. Allient is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allient	$554.48M	2.94	$22.03M	$1.43	67.15
Frequency Electronics	$69.81M	9.72	$23.69M	$0.75	91.96

Frequency Electronics has a net margin of 10.78% compared to Allient's net margin of 4.25%. Frequency Electronics' return on equity of 12.69% beat Allient's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allient	4.25%	12.47%	6.37%
Frequency Electronics	10.78%	12.69%	7.84%

Summary

Frequency Electronics beats Allient on 10 of the 17 factors compared between the two stocks.

How does Frequency Electronics compare to Alamar Biosciences?

Frequency Electronics (NASDAQ:FEIM) and Alamar Biosciences (NASDAQ:ALMR) are both small-cap measuring and control equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation, institutional ownership and media sentiment.

Frequency Electronics presently has a consensus price target of $43.67, indicating a potential downside of 36.69%. Alamar Biosciences has a consensus price target of $30.00, indicating a potential upside of 30.78%. Given Alamar Biosciences' higher probable upside, analysts clearly believe Alamar Biosciences is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Frequency Electronics has higher earnings, but lower revenue than Alamar Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Frequency Electronics	$69.81M	9.72	$23.69M	$0.75	91.96
Alamar Biosciences	$87.16M	18.24	N/A	N/A	N/A

58.6% of Frequency Electronics shares are owned by institutional investors. 28.0% of Frequency Electronics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Frequency Electronics' average media sentiment score of 1.00 beat Alamar Biosciences' score of 0.00 indicating that Frequency Electronics is being referred to more favorably in the media.

Company	Overall Sentiment
Frequency Electronics	Positive
Alamar Biosciences	Neutral

Frequency Electronics has a net margin of 10.78% compared to Alamar Biosciences' net margin of 0.00%. Frequency Electronics' return on equity of 12.69% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Frequency Electronics	10.78%	12.69%	7.84%
Alamar Biosciences	N/A	N/A	N/A

Summary

Frequency Electronics beats Alamar Biosciences on 8 of the 12 factors compared between the two stocks.

How does Frequency Electronics compare to Eyepoint Pharmaceuticals?

Eyepoint Pharmaceuticals (NASDAQ:EYPT) and Frequency Electronics (NASDAQ:FEIM) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

Frequency Electronics has a net margin of 10.78% compared to Eyepoint Pharmaceuticals' net margin of -3,566.63%. Frequency Electronics' return on equity of 12.69% beat Eyepoint Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Eyepoint Pharmaceuticals	-3,566.63%	-110.54%	-90.15%
Frequency Electronics	10.78%	12.69%	7.84%

Eyepoint Pharmaceuticals has a beta of 1.72, indicating that its stock price is 72% more volatile than the broader market. Comparatively, Frequency Electronics has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market.

99.4% of Eyepoint Pharmaceuticals shares are held by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are held by institutional investors. 5.1% of Eyepoint Pharmaceuticals shares are held by company insiders. Comparatively, 28.0% of Frequency Electronics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Eyepoint Pharmaceuticals had 1 more articles in the media than Frequency Electronics. MarketBeat recorded 1 mentions for Eyepoint Pharmaceuticals and 0 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 1.00 beat Eyepoint Pharmaceuticals' score of 0.00 indicating that Frequency Electronics is being referred to more favorably in the news media.

Company	Overall Sentiment
Eyepoint Pharmaceuticals	Neutral
Frequency Electronics	Positive

Eyepoint Pharmaceuticals presently has a consensus target price of $31.80, indicating a potential upside of 121.14%. Frequency Electronics has a consensus target price of $43.67, indicating a potential downside of 36.69%. Given Eyepoint Pharmaceuticals' higher probable upside, research analysts plainly believe Eyepoint Pharmaceuticals is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eyepoint Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	3.00
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

Frequency Electronics has higher revenue and earnings than Eyepoint Pharmaceuticals. Eyepoint Pharmaceuticals is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eyepoint Pharmaceuticals	$31.37M	38.43	-$231.96M	-$3.50	N/A
Frequency Electronics	$69.81M	9.72	$23.69M	$0.75	91.96

Summary

Frequency Electronics beats Eyepoint Pharmaceuticals on 9 of the 16 factors compared between the two stocks.

How does Frequency Electronics compare to Transcat?

Transcat (NASDAQ:TRNS) and Frequency Electronics (NASDAQ:FEIM) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

98.3% of Transcat shares are owned by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are owned by institutional investors. 2.8% of Transcat shares are owned by insiders. Comparatively, 28.0% of Frequency Electronics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Frequency Electronics has lower revenue, but higher earnings than Transcat. Frequency Electronics is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Transcat	$331.88M	2.52	$5.38M	$0.58	154.24
Frequency Electronics	$69.81M	9.72	$23.69M	$0.75	91.96

Transcat presently has a consensus price target of $105.33, indicating a potential upside of 17.74%. Frequency Electronics has a consensus price target of $43.67, indicating a potential downside of 36.69%. Given Transcat's higher possible upside, research analysts plainly believe Transcat is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Transcat	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

Frequency Electronics has a net margin of 10.78% compared to Transcat's net margin of 1.62%. Frequency Electronics' return on equity of 12.69% beat Transcat's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Transcat	1.62%	5.84%	3.78%
Frequency Electronics	10.78%	12.69%	7.84%

Transcat has a beta of 0.71, suggesting that its share price is 29% less volatile than the broader market. Comparatively, Frequency Electronics has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market.

In the previous week, Transcat had 3 more articles in the media than Frequency Electronics. MarketBeat recorded 3 mentions for Transcat and 0 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 1.00 beat Transcat's score of 0.16 indicating that Frequency Electronics is being referred to more favorably in the news media.

Company	Overall Sentiment
Transcat	Neutral
Frequency Electronics	Positive

Summary

Frequency Electronics beats Transcat on 9 of the 16 factors compared between the two stocks.

How does Frequency Electronics compare to Cytek Biosciences?

Frequency Electronics (NASDAQ:FEIM) and Cytek Biosciences (NASDAQ:CTKB) are both small-cap measuring and control equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, valuation, analyst recommendations, dividends, earnings and profitability.

In the previous week, Cytek Biosciences had 1 more articles in the media than Frequency Electronics. MarketBeat recorded 1 mentions for Cytek Biosciences and 0 mentions for Frequency Electronics. Frequency Electronics' average media sentiment score of 1.00 beat Cytek Biosciences' score of 0.76 indicating that Frequency Electronics is being referred to more favorably in the media.

Company	Overall Sentiment
Frequency Electronics	Positive
Cytek Biosciences	Positive

Frequency Electronics has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market. Comparatively, Cytek Biosciences has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market.

Frequency Electronics has a net margin of 10.78% compared to Cytek Biosciences' net margin of -36.25%. Frequency Electronics' return on equity of 12.69% beat Cytek Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Frequency Electronics	10.78%	12.69%	7.84%
Cytek Biosciences	-36.25%	-10.07%	-7.56%

58.6% of Frequency Electronics shares are held by institutional investors. Comparatively, 69.5% of Cytek Biosciences shares are held by institutional investors. 28.0% of Frequency Electronics shares are held by company insiders. Comparatively, 10.4% of Cytek Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Frequency Electronics currently has a consensus price target of $43.67, indicating a potential downside of 36.69%. Cytek Biosciences has a consensus price target of $5.69, indicating a potential upside of 39.74%. Given Cytek Biosciences' higher probable upside, analysts clearly believe Cytek Biosciences is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
Cytek Biosciences	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Frequency Electronics has higher earnings, but lower revenue than Cytek Biosciences. Cytek Biosciences is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Frequency Electronics	$69.81M	9.72	$23.69M	$0.75	91.96
Cytek Biosciences	$201.49M	2.61	-$66.54M	-$0.57	N/A

Summary

Frequency Electronics beats Cytek Biosciences on 11 of the 17 factors compared between the two stocks.

Get Frequency Electronics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FEIM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FEIM vs. The Competition

Export

Metric	Frequency Electronics	INSTRU Industry	Computer Sector	NASDAQ Exchange
Market Cap	$686.28M	$3.34B	$39.31B	$12.38B
Dividend Yield	N/A	0.95%	3.27%	5.83%
P/E Ratio	91.96	75.68	79.23	23.99
Price / Sales	9.72	3.74	622.73	106.82
Price / Cash	26.09	27.63	48.53	54.51
Price / Book	11.99	4.25	9.58	6.50
Net Income	$23.69M	$73.46M	$1.07B	$336.88M
7 Day Performance	-1.78%	-1.26%	-0.82%	-0.14%
1 Month Performance	1.41%	4.60%	0.98%	0.77%
1 Year Performance	207.90%	68.24%	156.64%	28.49%

Frequency Electronics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FEIM Frequency Electronics	1.5968 of 5 stars	$68.97 -1.1%	$43.67 -36.7%	+196.8%	$686.28M	$69.81M	91.96	200	Gap Up
ALNT Allient	2.4509 of 5 stars	$95.58 +0.5%	$77.33 -19.1%	+177.5%	$1.63B	$554.48M	67.18	2,478	Gap Down
ALMR Alamar Biosciences	4.3166 of 5 stars	$20.25 -2.1%	$30.00 +48.1%	N/A	$1.40B	$87.16M	N/A	222	Positive News
EYPT Eyepoint Pharmaceuticals	2.0905 of 5 stars	$12.39 +2.5%	$31.80 +156.8%	+73.7%	$1.04B	$31.37M	N/A	120
TRNS Transcat	3.2907 of 5 stars	$91.52 -0.1%	$105.33 +15.1%	+11.4%	$856.21M	$331.88M	158.06	1,413	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FEIM) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Frequency Electronics (FEIM) Competitors

FEIM vs. ALNT, ALMR, EYPT, TRNS, and CTKB

How does Frequency Electronics compare to Allient?

Summary

How does Frequency Electronics compare to Alamar Biosciences?

Summary

How does Frequency Electronics compare to Eyepoint Pharmaceuticals?

Summary

How does Frequency Electronics compare to Transcat?

Summary

How does Frequency Electronics compare to Cytek Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FEIM vs. The Competition

Frequency Electronics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Frequency Electronics (FEIM) Competitors

FEIM vs. ALNT, ALMR, EYPT, TRNS, and CTKB

How does Frequency Electronics compare to Allient?

Do insiders & institutionals hold more shares of ALNT or FEIM?

Do analysts prefer ALNT or FEIM?

Which has more risk & volatility, ALNT or FEIM?

Does the media prefer ALNT or FEIM?

Which has stronger earnings & valuation, ALNT or FEIM?

Is ALNT or FEIM more profitable?

Summary

How does Frequency Electronics compare to Alamar Biosciences?

Do analysts prefer FEIM or ALMR?

Which has stronger earnings & valuation, FEIM or ALMR?

Do insiders and institutionals have more ownership in FEIM or ALMR?

Does the media favor FEIM or ALMR?

Is FEIM or ALMR more profitable?

Summary

How does Frequency Electronics compare to Eyepoint Pharmaceuticals?

Is EYPT or FEIM more profitable?

Which has more risk & volatility, EYPT or FEIM?

Do insiders & institutionals believe in EYPT or FEIM?

Does the media favor EYPT or FEIM?

Do analysts prefer EYPT or FEIM?

Which has preferable earnings & valuation, EYPT or FEIM?

Summary

How does Frequency Electronics compare to Transcat?

Do institutionals and insiders believe in TRNS or FEIM?

Which has preferable valuation and earnings, TRNS or FEIM?

Do analysts recommend TRNS or FEIM?

Is TRNS or FEIM more profitable?

Which has more volatility and risk, TRNS or FEIM?

Does the media prefer TRNS or FEIM?

Summary

How does Frequency Electronics compare to Cytek Biosciences?

Does the media favor FEIM or CTKB?

Which has more risk & volatility, FEIM or CTKB?

Is FEIM or CTKB more profitable?

Do insiders & institutionals have more ownership in FEIM or CTKB?

Do analysts rate FEIM or CTKB?

Which has preferable earnings & valuation, FEIM or CTKB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FEIM vs. The Competition

Frequency Electronics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools